Stock MOLNRIPO J. MOLNER
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart J. Molner

Equities

MOLNRIPO

EE3100109034

Delayed Nasdaq Tallinn
Other stock markets
 04:04:03 2024-05-31 am EDT 		5-day change 1st Jan Change
13.9 EUR +4.51% Intraday chart for J. Molner -0.71% +1.09%
Apr. 30 J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4% CI
Mar. 04 J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
J. MOLNER
Generic Pharmaceuticals
+4.51%-0.71%+1.09%+167.31% - 25.42M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MOLNRIPO Stock
  4. Charts J. Molner
  5. Comparison Chart